Study Type
Interventional - Drug
ANNEXa-I is a randomized, multicenter, Phase 4 clinical trial of 440 patients designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracranial hemorrhage.
Interventional - Drug
Prospective open-label RCT
24
264
591
2019 - 2023
Alexion - AstraZeneca Rare Disease
Back To Top